rs374550999
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 11P and 1B. PM1PP3PP5_Very_StrongBP4
The NM_016042.4(EXOSC3):c.238G>T(p.Val80Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,608,334 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.00090 ( 6 hom., cov: 32)
Exomes 𝑓: 0.000083 ( 1 hom. )
Consequence
EXOSC3
NM_016042.4 missense
NM_016042.4 missense
Scores
8
7
4
Clinical Significance
Conservation
PhyloP100: 7.37
Genes affected
EXOSC3 (HGNC:17944): (exosome component 3) This gene encodes a non-catalytic component of the human exosome, a complex with 3'-5' exoribonuclease activity that plays a role in numerous RNA processing and degradation activities. Related pseudogenes of this gene are found on chromosome 19 and 21. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM1
In a chain Exosome complex component RRP40 (size 273) in uniprot entity EXOS3_HUMAN there are 8 pathogenic changes around while only 0 benign (100%) in NM_016042.4
PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Cadd, Eigen, M_CAP, PrimateAI, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
PP5
Variant 9-37784807-C-A is Pathogenic according to our data. Variant chr9-37784807-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 129024.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-37784807-C-A is described in Lovd as [Likely_pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.19264564). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOSC3 | NM_016042.4 | c.238G>T | p.Val80Phe | missense_variant | 1/4 | ENST00000327304.10 | NP_057126.2 | |
EXOSC3 | NM_001002269.2 | c.238G>T | p.Val80Phe | missense_variant | 1/3 | NP_001002269.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXOSC3 | ENST00000327304.10 | c.238G>T | p.Val80Phe | missense_variant | 1/4 | 1 | NM_016042.4 | ENSP00000323046.4 | ||
ENSG00000255872 | ENST00000540557.1 | n.*761-744G>T | intron_variant | 5 | ENSP00000457548.1 |
Frequencies
GnomAD3 genomes AF: 0.000900 AC: 137AN: 152252Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
137
AN:
152252
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000153 AC: 36AN: 234882Hom.: 0 AF XY: 0.000132 AC XY: 17AN XY: 128502
GnomAD3 exomes
AF:
AC:
36
AN:
234882
Hom.:
AF XY:
AC XY:
17
AN XY:
128502
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000831 AC: 121AN: 1455964Hom.: 1 Cov.: 30 AF XY: 0.0000773 AC XY: 56AN XY: 724310
GnomAD4 exome
AF:
AC:
121
AN:
1455964
Hom.:
Cov.:
30
AF XY:
AC XY:
56
AN XY:
724310
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000899 AC: 137AN: 152370Hom.: 6 Cov.: 32 AF XY: 0.000953 AC XY: 71AN XY: 74506
GnomAD4 genome
AF:
AC:
137
AN:
152370
Hom.:
Cov.:
32
AF XY:
AC XY:
71
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
12
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Pontocerebellar hypoplasia type 1B Pathogenic:6Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 80 of the EXOSC3 protein (p.Val80Phe). This variant is present in population databases (rs374550999, gnomAD 0.04%). This missense change has been observed in individual(s) with pontocerebellar hypoplasia (PMID: 23975261, 25809939). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 129024). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EXOSC3 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | May 20, 2023 | The observed missense c.238G>T(p.Val80Phe) variant in EXOSC3 gene has been reported previously in compound heterozygous state in individual(s) affected with intellectual disability, early onset spasticity, and cerebellar atrophy detects (Zanni et al., 2013). This variant is reported with the allele frequency of 0.02% in the gnomAD Exomes. This variant has been reported to the ClinVar database as Likely Pathogenic / Pathogenic (multiple submitters). The amino acid Val at position 80 is changed to a Phe changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Val80Phe in EXOSC3 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. Multiple lines of computational evidence (Polyphen - Possibly Damaging, SIFT - Damaging, and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. For these reasons, this variant has been classified as Pathogenic. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 21, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 13, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2013 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 27, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30609409, 23975261, 24524299, 29656927, 29093021, 27219052, 34532947, 34426522, 25809939) - |
Pontoneocerebellar hypoplasia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 10, 2016 | The p.Val80Phe variant in EXOSC3 has been reported in 2 families with pontocereb ellar hypoplasia in the compound heterozygous state (Zanni 2013; Li 2013) and in one of the families the variant segregated in the 2 affected siblings (Zanni 20 13). This variant has been described in 0.05% (7/14042) of South Asian chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; rs 374550999). Although this variant has been seen in the general population, its f requency is low enough to be consistent with a recessive carrier frequency. Com putational prediction tools and conservation analysis suggest the variant may im pact the protein function, though this information is not predictive enough to d etermine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, the p.Val80Phe variant is likely path ogenic for pontocerebellar hypoplasia in an autosomal recessive manner based upo n allelic observations in affected individuals. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Benign
T;D
Sift4G
Uncertain
D;D
Polyphen
P;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at